PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 93 filers reported holding PLIANT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,700,268 | -9.6% | 1,597,478 | -5.5% | 0.01% | 0.0% |
| Q2 2023 | $30,639,234 | -5.2% | 1,690,907 | +39.2% | 0.01% | -14.3% |
| Q1 2023 | $32,311,765 | +57.4% | 1,214,728 | +14.4% | 0.01% | +75.0% |
| Q4 2022 | $20,526,933 | +90.7% | 1,061,921 | +106.1% | 0.00% | +100.0% |
| Q3 2022 | $10,765,000 | -4.3% | 515,288 | -63.3% | 0.00% | -33.3% |
| Q2 2022 | $11,244,000 | +16.4% | 1,403,627 | +1.9% | 0.00% | +50.0% |
| Q1 2022 | $9,657,000 | -46.5% | 1,377,508 | +3.0% | 0.00% | -50.0% |
| Q4 2021 | $18,051,000 | -20.4% | 1,337,126 | -0.4% | 0.00% | -20.0% |
| Q3 2021 | $22,673,000 | -35.0% | 1,343,166 | +12.1% | 0.01% | -37.5% |
| Q2 2021 | $34,898,000 | -27.4% | 1,198,405 | -1.9% | 0.01% | -33.3% |
| Q1 2021 | $48,068,000 | +71.7% | 1,222,180 | -0.8% | 0.01% | +71.4% |
| Q4 2020 | $27,997,000 | +0.5% | 1,232,258 | +0.2% | 0.01% | -12.5% |
| Q3 2020 | $27,847,000 | -30.4% | 1,229,433 | -0.3% | 0.01% | -42.9% |
| Q2 2020 | $40,016,000 | – | 1,232,780 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 1,839,160 | $35,550,963 | 27.86% |
| TRV GP IV, LLC | 2,132,867 | $41,228,319 | 17.53% |
| CHI Advisors LLC | 3,169,892 | $61,274,012 | 16.32% |
| GREAT POINT PARTNERS LLC | 1,322,870 | $25,571,077 | 5.01% |
| VR Adviser, LLC | 1,080,000 | $20,876,400 | 3.52% |
| Redmile Group, LLC | 3,878,599 | $74,973,319 | 3.07% |
| Casdin Capital, LLC | 1,675,000 | $32,377,750 | 2.51% |
| Fernwood Investment Management, LLC | 304,573 | $5,887,396 | 2.44% |
| Cheyne Capital Management (UK) LLP | 66,144 | $1,278,564 | 2.23% |
| First Light Asset Management, LLC | 1,057,881 | $20,448,840 | 1.90% |